Literature DB >> 16215261

Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand.

Lumelle A Schneeweis1, Derril Willard, Marcos E Milla.   

Abstract

The receptor activator of NF-kappaB (RANK) belongs to the neuregulin/tumor necrosis factor (TNF) receptor superfamily and is activated by RANK ligand (RANK-L), a homotrimeric, TNF-like cytokine. RANK is present on the surface of osteoclast cell precursors, where its interaction with RANK-L induces their terminal differentiation into osteoclasts, thus increasing bone breakdown. The secreted, soluble receptor osteoprotegerin (OPG) interrupts this activation by binding directly to RANK-L. Therefore, osteoclast maturation (and bone homeostasis) is regulated in vivo by OPG levels of expression. We have studied the assembly state and affinity of OPG for RANK-L by sedimentation analyses and surface plasmon resonance (Biacore). Full-length, homodimeric OPG binds to RANK-L with a KD of 10 nM. OPG is also a member of the TNF receptor superfamily and contains four disulfide-rich ligand-binding domains, yet lacks a transmembrane region separating the ligand-binding region from the two death domains, as observed for other receptor family members. We showed that dimerization of OPG results from noncovalent interactions mediated by the death domains and to a lesser extent by a C-terminal heparin-binding region. In contrast, a C-terminal intermolecular disulfide bond does not contribute to the formation or stability of OPG dimers. A truncate of osteoprotegerin, containing the ligand-binding domains but lacking the dimerization domains, bound RANK-L with a KD of approximately 3 microM, indicating that monomer oligomerization for the OPG provides an increase of 3 orders of magnitude in the affinity for RANK-L. Therefore, OPG dimer formation is required for the mechanism of inhibition of the RANK-L/RANK receptor interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215261     DOI: 10.1074/jbc.M506366200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Authors:  Isabell Lang; Simone Füllsack; Agnes Wyzgol; Andrea Fick; Johannes Trebing; José Antonio Carmona Arana; Viktoria Schäfer; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.

Authors:  Tomohito Akiyama; Yoichi Miyamoto; Kentaro Yoshimura; Atsushi Yamada; Masamichi Takami; Tetsuo Suzawa; Marie Hoshino; Takahisa Imamura; Chie Akiyama; Rika Yasuhara; Kenji Mishima; Toshifumi Maruyama; Chikara Kohda; Kazuo Tanaka; Jan Potempa; Hisataka Yasuda; Kazuyoshi Baba; Ryutaro Kamijo
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

Review 3.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

4.  Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members.

Authors:  Julia T Warren; Christopher A Nelson; Corinne E Decker; Wei Zou; Daved H Fremont; Steven L Teitelbaum
Journal:  Sci Signal       Date:  2014-08-19       Impact factor: 8.192

Review 5.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

6.  Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus.

Authors:  Li Long; Yanying Liu; Shiyao Wang; Yi Zhao; Jianping Guo; Ping Yu; Zhanguo Li
Journal:  J Clin Immunol       Date:  2010-06-30       Impact factor: 8.317

7.  RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis.

Authors:  J T Ney; T Fehm; I Juhasz-Boess; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-05       Impact factor: 2.915

8.  RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.

Authors:  Christopher A Nelson; Julia T Warren; Michael W-H Wang; Steven L Teitelbaum; Daved H Fremont
Journal:  Structure       Date:  2012-10-02       Impact factor: 5.006

9.  Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.

Authors:  Miaomiao Li; Shuying Yang; Ding Xu
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

10.  Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro.

Authors:  Seicho Makihira; Yuichi Mine; Hiroki Nikawa; Takahiro Shuto; Eduardo Kosaka; Masaru Sugiyama; Ryuji Hosokawa
Journal:  J Mater Sci Mater Med       Date:  2009-10-16       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.